WARNING: This product is for research use only, not for human or veterinary use.
MedKoo CAT#: 525038
Description: Fanetizole mesylate is an immunoregulator agent.
MedKoo Cat#: 525038
Name: Fanetizole mesylate
Chemical Formula: C18H20N2O3S2
Molecular Weight: 376.49
Elemental Analysis: C, 57.42; H, 5.35; N, 7.44; O, 12.75; S, 17.03
This product is not in stock, which may be available by custom synthesis.
For cost-effective reason, minimum order is 1g (price is usually high, lead time is 2~3 months, depending on the technical challenge).
Quote less than 1g will not be provided. To request quote, please email to sales @medkoo.com or click below button.
Note: Price will be listed if it is available in the future.
Synonym: Fanetizole mesylate; UNII-D3OG7B0G4M; Fanetizole mesylate (USAN); Fanetizole mesylate [USAN]; C1MHW3X; CP 48810; CP-48,810; fanetizole.
IUPAC/Chemical Name: 2-(Phenethylamino)-4-phenylthiazole monomethanesulfonate
InChi Key: FHXKFCNUYSGNFV-UHFFFAOYSA-N
InChi Code: InChI=1S/C17H16N2S.CH4O3S/c1-3-7-14(8-4-1)11-12-18-17-19-16(13-20-17)15-9-5-2-6-10-15;1-5(2,3)4/h1-10,13H,11-12H2,(H,18,19);1H3,(H,2,3,4)
SMILES Code: CS(=O)(=O)O.c1ccc(cc1)CCNc2nc(cs2)c3ccccc3
Appearance: Solid powder
Purity: >98% (or refer to the Certificate of Analysis)
Shipping Condition: Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition: Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility: Soluble in DMSO, not in water
Shelf Life: >2 years if stored properly
Drug Formulation: This drug may be formulated in DMSO
Stock Solution Storage: 0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code: 2934.99.9001
The following data is based on the product molecular weight 376.49 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.
|Concentration / Solvent Volume / Mass||1 mg||5 mg||10 mg|
|1 mM||1.15 mL||5.76 mL||11.51 mL|
|5 mM||0.23 mL||1.15 mL||2.3 mL|
|10 mM||0.12 mL||0.58 mL||1.15 mL|
|50 mM||0.02 mL||0.12 mL||0.23 mL|
1: Styrt B, Rocklin RE, Klempner MS. Inhibition of neutrophil superoxide production by fanetizole. Inflammation. 1985 Sep;9(3):233-44. PubMed PMID: 2995253.
2: Antonacci AC. How do immunomodulators affect host defense in the burn patient? J Trauma. 1984 Sep;24(9 Suppl):S101-18. PubMed PMID: 6384529.
3: Rocklin RE, Hemady Z, Matloff S, Kiselis I, Lima M. Correction of an in vitro immunoregulatory defect in atopic subjects by the immunostimulating drug fanetizole mesylate (CP-48,810). Int J Immunopharmacol. 1984;6(1):1-8. PubMed PMID: 6233230.